subscribe: Posts | Comments

‘Stay on Tamoxifen’ women told

0 comments

Summary of story from BBC, March 22, 2011.

Women who cut short their Tamoxifen treatment before the recommended full five years risk their breast cancer returning, experts warn.

Up to half of women stop taking the drug prematurely but in doing so significantly reduce their survival odds, says Cancer Research UK.

Data shows for every hundred women who complete the full course, six fewer will have a recurrence of their cancer.  Tamoxifen is usually given to women with oestrogen-sensitive breast cancer.

Kate Law of Cancer Research UK said: “It’s vital that doctors and nurses continue encouraging women to finish their course of tamoxifen and providing the necessary support to ensure any side-effects are effectively managed.

“We would urge anyone who experiences problems taking their medication to consult their doctor without delay.”

Leave a Reply

Your email address will not be published. Required fields are marked *